We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$778M
AUM Growth
-$1.85M
Cap. Flow
-$35.3M
Cap. Flow %
-4.54%
Top 10 Hldgs %
34.42%
Holding
5,522
New
919
Increased
1,531
Reduced
1,579
Closed
1,330

Sector Composition

Rank Sector Weight
1 Industrials 6%
2 Financials 5.45%
3 Technology 5.24%
4 Consumer Discretionary 4.75%
5 Healthcare 3.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCRX icon
2526
Pacira BioSciences
PCRX
$991M
$8K ﹤0.01%
+90
New +$6.85K
PFL
2527
PIMCO Income Strategy Fund
PFL
$386M
$8K ﹤0.01%
+680
New +$8.19K
RXI icon
2528
iShares Global Consumer Discretionary ETF
RXI
$275M
$8K ﹤0.01%
+100
New +$8.23K
RZG icon
2529
Invesco S&P SmallCap 600 Pure Growth ETF
RZG
$143M
$8K ﹤0.01%
300
+12
+4% +$309
SF
2530
Stifel
SF
$12.8B
$8K ﹤0.01%
378
-4,581
-92% -$94.4K
SIF icon
2531
SIFCO Industries
SIF
$169M
$8K ﹤0.01%
266
+252
+1,800% +$8.36K
TATT icon
2532
TAT Technologies
TATT
$554M
$8K ﹤0.01%
1,157
-332
-22% -$2.59K
TGB
2533
Trekor Metals
TGB
$2.99B
$8K ﹤0.01%
3,042
-7,037
-70% -$15.2K
TGTX icon
2534
TG Therapeutics
TGTX
$7.64B
$8K ﹤0.01%
801
-1,369
-63% -$8.75K
THS
2535
DELISTED
Treehouse Foods
THS
$8K ﹤0.01%
98
-444
-82% -$33.1K
VIDI icon
2536
Vident International Equity Strategy
VIDI
$443M
$8K ﹤0.01%
304
-393
-56% -$9.93K
WPM icon
2537
Wheaton Precious Metals
WPM
$55.8B
$8K ﹤0.01%
300
-1,451
-83% -$32.5K
XHE icon
2538
State Street SPDR S&P Health Care Equipment ETF
XHE
$161M
$8K ﹤0.01%
+198
New +$7.53K
XRAY icon
2539
Dentsply Sirona
XRAY
$2.76B
$8K ﹤0.01%
155
-1,007
-87% -$46.8K
QCLS
2540
Q/C Technologies Inc
QCLS
$23.2M
0
MAGN
2541
Magnera Corp
MAGN
$482M
$8K ﹤0.01%
22
+20
+1,000% +$6.81K
MCBC
2542
DELISTED
Macatawa Bank Corp
MCBC
$8K ﹤0.01%
1,461
+1,221
+509% +$6.13K
AFT
2543
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
$8K ﹤0.01%
448
EIGR
2544
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$8K ﹤0.01%
1
-5
-83% -$25K
MTEM
2545
DELISTED
Molecular Templates, Inc.
MTEM
$8K ﹤0.01%
13
+2
+18% +$1.32K
VTA
2546
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$8K ﹤0.01%
600
-178
-23% -$2.3K
LBY
2547
DELISTED
Libbey, Inc.
LBY
$8K ﹤0.01%
292
+133
+84% +$3.53K
FGP
2548
DELISTED
Ferrellgas Partners, L.P.
FGP
$8K ﹤0.01%
293
+39
+15% +$1K
DEST
2549
DELISTED
Destination Maternity Corporation
DEST
$8K ﹤0.01%
+372
New +$9.09K
CWAY
2550
DELISTED
Coastway Bancorp, Inc.
CWAY
$8K ﹤0.01%
+742
New +$7.66K

Similar funds

Tower Research Capital (TRC)'s Q2 2014 Portfolio in Review

As of Q2 2014, Tower Research Capital (TRC) held 5,522 positions worth $778M, down 0.24% from $780M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $35.3M in Q2 2014, closing 1,330 positions and reducing 1,579 holdings. Its most notable exit was iShares Core S&P Small-Cap ETF, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 6% of assets, up from 5.1% a quarter earlier, followed by Financials and Technology.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $9.03M.

  • Tower Research Capital (TRC)'s largest Q2 2014 buy was iShares Russell 1000 Value ETF: 89,185 shares worth $9.03M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2014, an estimated $177M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2014 reduction was Invesco QQQ Trust, cutting an estimated $110M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Small-Cap ETF in Q2 2014, selling an estimated $10.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $778M portfolio in Q2 2014.
  • Tower Research Capital (TRC) opened 919 new positions and closed 1,330 in Q2 2014.
  • Tower Research Capital (TRC)'s portfolio value fell 0.24% quarter-over-quarter to $778M.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2014, filed 14 Aug 2014.